Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S John

Showing results (1051-1060 of 1,133) with videos related to

Pageof 114
Sort By:
Medrxiv : the Preprint Server for Health Sciences|December 3, 2025
A Randomized Hybrid Type I Effectiveness-Implementation Study of an eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Cancer (eREACH2): study protocolE Mastaglio, B Egleston, K T Lee, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 31, 2023
Endothelial Cell <i>APOE3</i> Regulates Neurovascular, Neuronal, and Behavioral FunctionFelecia M Marottoli, Hui Zhang, Eden Flores-Barrera, et al.
Journal of the National Cancer Institute|May 23, 2018
Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic VirotherapyCheyne Kurokawa, Ianko D Iankov, S Keith Anderson, et al.
Pulmonary Circulation|April 15, 2020
Idiopathic pulmonary arterial hypertension and co-existing lung disease: is this a new phenotype?Andrew J Peacock, Yi Ling, Martin K Johnson, et al.
American Journal of Respiratory and Critical Care Medicine|July 17, 2012
Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and IrelandYi Ling, Martin K Johnson, David G Kiely, et al.
Gynecologic Oncology|September 12, 2016
In vivo anti-tumor activity of the PARP inhibitor niraparib in homologous recombination deficient and proficient ovarian carcinomaMariam M AlHilli, Marc A Becker, S John Weroha, et al.
Nature Genetics|May 17, 2024
Spatial genomic, biochemical and cellular mechanisms underlying meningioma heterogeneity and evolutionCalixto-Hope G Lucas, Kanish Mirchia, Kyounghee Seo, et al.
Cell Reports|February 6, 2020
Multiplatform Molecular Profiling Reveals Epigenomic Intratumor Heterogeneity in EpendymomaS John Liu, Stephen T Magill, Harish N Vasudevan, et al.
British Journal of Sports Medicine|April 28, 2017
The Sport Concussion Assessment Tool 5th Edition (SCAT5): Background and rationaleRuben J Echemendia, Willem Meeuwisse, Paul McCrory, et al.
Genome Biology|April 3, 2020
CRISPRi-based radiation modifier screen identifies long non-coding RNA therapeutic targets in gliomaS John Liu, Martina Malatesta, Brian V Lien, et al.
Pageof 114

Showing results (1051-1060 of 1,133) with videos related to

Sort By:
Pageof 114
Medrxiv : the Preprint Server for Health Sciences|December 3, 2025
A Randomized Hybrid Type I Effectiveness-Implementation Study of an eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Cancer (eREACH2): study protocolE Mastaglio, B Egleston, K T Lee, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 31, 2023
Endothelial Cell <i>APOE3</i> Regulates Neurovascular, Neuronal, and Behavioral FunctionFelecia M Marottoli, Hui Zhang, Eden Flores-Barrera, et al.
Journal of the National Cancer Institute|May 23, 2018
Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic VirotherapyCheyne Kurokawa, Ianko D Iankov, S Keith Anderson, et al.
Pulmonary Circulation|April 15, 2020
Idiopathic pulmonary arterial hypertension and co-existing lung disease: is this a new phenotype?Andrew J Peacock, Yi Ling, Martin K Johnson, et al.
American Journal of Respiratory and Critical Care Medicine|July 17, 2012
Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and IrelandYi Ling, Martin K Johnson, David G Kiely, et al.
Gynecologic Oncology|September 12, 2016
In vivo anti-tumor activity of the PARP inhibitor niraparib in homologous recombination deficient and proficient ovarian carcinomaMariam M AlHilli, Marc A Becker, S John Weroha, et al.
Nature Genetics|May 17, 2024
Spatial genomic, biochemical and cellular mechanisms underlying meningioma heterogeneity and evolutionCalixto-Hope G Lucas, Kanish Mirchia, Kyounghee Seo, et al.
Cell Reports|February 6, 2020
Multiplatform Molecular Profiling Reveals Epigenomic Intratumor Heterogeneity in EpendymomaS John Liu, Stephen T Magill, Harish N Vasudevan, et al.
British Journal of Sports Medicine|April 28, 2017
The Sport Concussion Assessment Tool 5th Edition (SCAT5): Background and rationaleRuben J Echemendia, Willem Meeuwisse, Paul McCrory, et al.
Genome Biology|April 3, 2020
CRISPRi-based radiation modifier screen identifies long non-coding RNA therapeutic targets in gliomaS John Liu, Martina Malatesta, Brian V Lien, et al.
Pageof 114